ELIXA, NCT01147250 / 2009-012852-26: Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide) |
|
|
| Completed | 3 | 6068 | Europe, Canada, Japan, US, RoW | Lixisenatide (AVE0010), Lyxumia, Placebo | Sanofi | Acute Coronary Syndrome | 02/15 | 02/15 | | |
